Telix Pharmaceuticals to host R&D Day for institutional investors and analystsPUBT·9 hours agoTLX+1.26%
How Investors May Respond To Telix Pharmaceuticals (ASX:TLX) Upgraded FY26 Guidance And Pipeline MilestonesSimplywall·Aug 2 at 06:12 AMTLX+1.26%REGN+1.04%
Telix H1 2026 Results: Investor Webcast Notification | TLX Stock NewsStockTitan·Jul 30 at 09:37 AMTLX+1.26%
3 Australian Growth Stocks With High Insider Ownership Worth A Closer LookSimplywall·Jul 23 at 08:07 AM
Telix Pharmaceuticals Q2 Revenue Climbs Boosted By Precision Medicine Businessrttnews·Jul 21 at 12:45 AMTLX+1.26%
3 Australian Growth Stocks Trading Below Fair Value With Strong Insider BackingSimplywall·Jul 21 at 12:09 AMTLX+1.26%
Telix Pharmaceuticals reports Q2 results; updates FY2026 outlookbusinessinsider·Jul 20 at 11:30 PMTLX+1.26%
Bell Potter Sticks to Its Buy Rating for Telix Pharmaceuticals (TLPPF)Tip Ranks·Jul 20 at 07:35 PMTLX+1.26%
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress | TLX Stock NewsStockTitan·Jul 20 at 10:31 AMTLX+1.26%REGN+1.04%
